Current advances in our understanding of circular RNA (circRNA) in Alzheimer’s disease (AD); the potential utilization of synthetic circRNAs as a therapeutic strategy in the clinical management of AD-Reference-Cited by-同舟云学术

Current advances in our understanding of circular RNA (circRNA) in Alzheimer’s disease (AD); the potential utilization of synthetic circRNAs as a therapeutic strategy in the clinical management of AD

Published:2022-08-24 Issue: Volume:2 Page:
ISSN:2674-0338
Container-title:Frontiers in Drug Discovery
language:
Short-container-title:Front. Drug. Discov.

Author:

Zhao Yuhai,Jaber Vivian R.,Lukiw Walter J.

Funder

Joe W. and Dorothy Dorsett Brown Foundation

National Institutes of Health

Publisher

Frontiers Media SA

Reference74 articles.

1. Circular RNA and Alzheimer's disease;Akhter;Adv. Exp. Med. Biol.,2018

2. An English translation of Alzheimer’s 1907 paper, “Uber eine eigenartige Erkankung der Hirnrinde”;Alzheimer;Clin. Anat.,1995

3. Metazoan microRNAs;Bartel;Cell,2018

4. New insights into the genetic etiology of Alzheimer's disease and related dementias;Bellenguez;Nat. Genet.,2022

5. microRNA-34a-mediated down-regulation of the microglial-enriched triggering receptor and phagocytosis-sensor TREM2 in age-related macular degeneration;Bhattacharjee;PLoS One,2016

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Parkinson’s Disease and MicroRNAs: A Duel Between Inhibition and Stimulation of Apoptosis in Neuronal Cells;Molecular Neurobiology;2024-03-23

2. Circular RNA SLC8A1 triggers hippocampal neuronal ferroptosis by regulating FUS-mediated ATF3 mRNA stability in epilepsy;Experimental Cell Research;2024-01

3. An interpretable Alzheimer’s disease oligogenic risk score informed by neuroimaging biomarkers improves risk prediction and stratification;Frontiers in Aging Neuroscience;2023-10-26

4. Protein-coding circular RNAs – mechanism, detection, and their role in cancer and neurodegenerative diseases;Biochemical and Biophysical Research Communications;2023-10

5. Editorial: Disease-modifying targets and strategies for Alzheimer's disease and Parkinson's disease;Frontiers in Aging Neuroscience;2023-07-14